| Exec date | Filing date | Company | Role | Signal | Confidence | Shares | % of shares | Under plan? | Amount (USD) |
|---|---|---|---|---|---|---|---|---|---|
| Dec 10, 2025 | Dec 12, 2025 | Axogen, Inc. | CEO | Sell | 20.0 | -25,000 | -28.24% | ✗ | $750K |
| Dec 9, 2025 | Dec 10, 2025 | Axogen, Inc. | CEO | Sell | 37.5 | -61,463 | -40.98% | ✗ | $1.9M |
| Feb 28, 2023 | Mar 2, 2023 | ABBOTT LABORATORIES | President | Sell | 22.5 | -6,151 | -11.99% | ✓ | $614.8K |
| Mar 8, 2022 | Mar 10, 2022 | ABBOTT LABORATORIES | President | Sell | 20.0 | -4,000 | -8.74% | ✗ | $468K |
| Feb 28, 2022 | Mar 2, 2022 | ABBOTT LABORATORIES | President | Sell | 22.5 | -5,558 | -10.83% | ✓ | $675.9K |
| Jul 28, 2021 | Jul 30, 2021 | ABBOTT LABORATORIES | President | Sell | 17.5 | -17,600 | -30.72% | ✗ | $2.1M |
| Feb 26, 2021 | Mar 2, 2021 | ABBOTT LABORATORIES | President | Sell | 22.5 | -5,475 | -12.12% | ✓ | $664.2K |
| Feb 28, 2020 | Mar 3, 2020 | ABBOTT LABORATORIES | President | Sell | 28.8 | -2,934 | -7.78% | ✓ | $231.3K |
| Feb 17, 2020 | Feb 19, 2020 | ABBOTT LABORATORIES | President | Sell | 32.5 | -1,347 | -5.33% | ✓ | $120.5K |